Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Three-Year Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC—Update from PACIFIC
PaperCitations, authors & open-access status
Three-Year Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC—Update from PACIFIC is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 435 citations, 2019 year and hybrid oa status.
435
Citations
2019
Year
hybrid
OA Status